Scholar Rock, Inc.

ACTIVE

301 Binney St Ste 3, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.scholarrock.comPublic101–250 employeesEstablished: 2012-01-01

Part of scholar rock holding corp.

Clinical Trials

14 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

57.1%

Phase 2

21.4%

Phase 3

17.9%

Trial Status Distribution

Active, not recruiting

46.4%

Completed

21.4%

No Longer Available

3.6%

Not yet recruiting

3.6%

Recruiting

25.0%

Clinical Trials

Trials sponsored by this organization (28)

Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD

Phase 2

Recruiting

interventional

Jul 202660 participants

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Phase 2

Recruiting

interventional

Sep 202552 participants

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

Phase 2

Completed

interventional

May 2024102 participants

ong-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab.

Phase 1

Recruiting

interventional

Mar 2024236 participants

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

Phase 3

Active, not recruiting

interventional

Apr 2023238 participants

ong-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab

Phase 1

Active, not recruiting

interventional

Jan 2023260 participants

ong-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab

Phase 1

Active, not recruiting

interventional

Jan 2023260 participants

ong-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab

Phase 1

Active, not recruiting

interventional

Dec 2022260 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations